The generic version of aripiprazole is expected to be available in December 2024. This follows the expiration of certain patents that have protected the original drug, Abilify.
When does the patent for Abilify expire?
The primary patent protecting Abilify (aripiprazole) has already expired [1]. However, multiple secondary patents and exclusivities were in place, delaying generic availability. The key patent expiration that allows for broader generic entry is anticipated in December 2024 [1][2].
What does this mean for aripiprazole prices?
The introduction of generic aripiprazole in December 2024 is expected to lead to a significant decrease in the drug's price [3]. Generic medications are typically much less expensive than their branded counterparts due to increased competition.
Who manufactures generic aripiprazole?
Several pharmaceutical companies are poised to manufacture and market generic versions of aripiprazole once the patent protections fully expire. Companies like Teva Pharmaceuticals and Mylan (now part of Viatris) have been involved in the development and litigation surrounding generic aripiprazole [4][5].
Are there already generic versions of aripiprazole?
While some generic versions of aripiprazole have been available for specific formulations, the full market entry for all formulations is tied to the December 2024 patent expiration [1]. This date marks the point when comprehensive generic competition is anticipated for the most widely used forms of the drug.
How does aripiprazole work?
Aripiprazole is an atypical antipsychotic medication that works by modulating the activity of neurotransmitters in the brain, primarily dopamine and serotonin [6]. It is thought to act as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, and an antagonist at serotonin 5-HT2A receptors [6]. This mechanism helps to rebalance these chemicals, which can improve symptoms of conditions like schizophrenia and bipolar disorder.
What conditions is aripiprazole used to treat?
Aripiprazole is prescribed to treat a range of mental health conditions, including schizophrenia, bipolar I disorder (manic and mixed episodes), and major depressive disorder (as an add-on treatment) [6]. It is also used to treat irritability associated with autistic disorder and Tourette's disorder [6].
What are the side effects of aripiprazole?
Common side effects of aripiprazole can include nausea, vomiting, constipation, headache, dizziness, drowsiness, and akathisia (a feeling of inner restlessness) [7]. More serious, though less common, side effects can include tardive dyskinesia, neuroleptic malignant syndrome, and metabolic changes such as weight gain and increased blood sugar [7].
What are the alternatives to aripiprazole?
Other atypical antipsychotics like risperidone, olanzapine, quetiapine, and ziprasidone are alternatives to aripiprazole, as are other classes of medications depending on the specific condition being treated [8]. For major depressive disorder, other augmentation strategies might include different antidepressants or psychotherapy [8].
How does aripiprazole compare to other antipsychotics?
Aripiprazole is classified as an atypical antipsychotic, similar to drugs like risperidone and olanzapine. It is often distinguished by its partial agonism at dopamine D2 receptors, which may contribute to a lower incidence of certain side effects like extrapyramidal symptoms and hyperprolactinemia compared to some older antipsychotics [9]. However, individual responses to medications can vary.
Sources:
[1] DrugPatentWatch.com
[2] DrugPatentWatch.com
[3] DrugPatentWatch.com
[4] DrugPatentWatch.com
[5] DrugPatentWatch.com
[6] National Institute of Mental Health
[7] Mayo Clinic
[8] National Alliance on Mental Illness
[9] American Psychiatric Association